Eric Lefebvre
Directeur Technique/Scientifique/R&D chez PLIANT THERAPEUTICS, INC.
Fortune : 1 M $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Ho Young Huh | M | 54 | 7 ans | |
| Bernard Coulie | M | 58 | 8 ans | |
| David Pyott | M | 70 | 3 ans | |
| Smital Shah | F | 48 | 5 ans | |
| Katharine Knobil | M | 60 | 2 ans | |
| Christopher Keenan | M | - | 4 ans | |
| Suzanne Bruhn | M | 60 | 8 ans | |
| Monica Sandberg | M | - | 5 ans | |
| Bill DeGrado | M | - | 9 ans | |
| John Curnutte | M | 72 | 7 ans | |
| Darren Cline | M | 59 | 1 ans | |
| Thomas McCourt | M | 66 | 1 ans | |
| Gayle Crowell | F | 73 | 4 ans | |
| Mike Ouimette | M | 51 | 4 ans | |
| Alexandre Curzi | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
 Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Chantal Champagne | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | 9 ans |
| Gregory P. Cosgrove | M | - | 3 ans | |
| Katerina Leftheris | F | - | - | |
| Rik Derynck | M | - | - | |
| Alex Thurman | M | 54 | 8 ans | |
| Scott Peters | M | - | 3 ans | |
| Marie Christine Cojocaru | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Mishima Gerhart | F | - | 1 ans | |
| Laurent Dubois | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Keith Cummings | M | 47 | 6 ans | |
| Louise Lantagne | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sophie Prégent | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sophie Labesse | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Hal Chapman | M | - | 9 ans | |
| Dean Sheppard | M | - | 9 ans | |
| Gilles Labranche | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sylvie Jacques | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Hans Hull | M | 49 | 8 ans | |
| Luc Fortin | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Lily Cheung | F | 51 | 1 ans | |
| Scott Turner | M | 53 | 3 ans | |
| Minnie Kuo | F | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Sujal Shah | M | 50 | 12 ans | |
| Ambrose Bailey | M | 60 | - | |
| Laurent Fischer | M | 60 | 5 ans | |
| Paul Quinlan | M | 61 | 7 ans | |
| Michael Metzger | M | 53 | - | |
| Robert Wills | M | 70 | 9 ans | |
| Carol Brosgart | M | 72 | 7 ans | |
| Stephen M. Kaufhold | M | - | - | |
| Pamela Vig | M | 53 | 1 ans | |
| Joseph H. Boccuzi | M | 77 | 3 ans | |
| Roger J. Lias | M | 63 | 6 ans | |
| Neil Exter | M | 65 | 7 ans | |
| Ian Clements | M | 55 | 1 ans | |
| David Hovland | M | - | 8 ans | |
| Daphne Karydas | F | 49 | 3 ans | |
| Pierre Legault | M | 63 | 2 ans | |
| Daniel Menold | M | 54 | 10 ans | |
| Klara Dickinson-Eason | F | 57 | 7 ans | |
| Dennis Podlesak | M | 66 | 1 ans | |
| Gwen Melincoff | M | 72 | 2 ans | |
| Jeffrey Cooper | M | 68 | 1 ans | |
| Adriane Brown | M | 65 | 3 ans | |
| Andrew Fromkin | M | 58 | 1 ans | |
| Harish Shantharam | M | 44 | 1 ans | |
| Michael R. Gallagher | M | 77 | 2 ans | |
| Charles Homcy | M | 75 | 7 ans | |
| Eckard Weber | M | 73 | 1 ans | |
| Tamar Howson | F | 75 | 9 ans | |
| Thomas Wiggans | M | 72 | 3 ans | |
| Kurt von Emster | M | 56 | 15 ans | |
| Caroline Loewy | F | 58 | 8 ans | |
| Patrick Heron | M | 53 | 1 ans | |
| Cornelia Haag-Molkenteller | M | 66 | 11 ans | |
| Herm Cukier | M | 57 | 5 ans | |
| Kimberly Park | F | 60 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 5 ans |
| Janet Dorling | F | 50 | 3 ans | |
| Star Seyedkazemi | M | 50 | 1 ans | |
| David Bharucha | M | 62 | 4 ans | |
| Patricia Rohane | M | - | 6 ans | |
| Elizabeth Anderson | F | 66 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 11 ans |
| Sanjiv Patel | M | 50 | 11 ans | |
| Barbara Howes | F | 59 | 2 ans | |
| Christi Shaw | F | 57 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 1 ans |
| Perry Karsen | M | 69 | - | |
| Christopher Peetz | M | 45 | 2 ans | |
| Patrick J. O'Mara | M | 62 | 33 ans | |
| Carolyn Myers | M | 66 | 6 ans | |
| Kenneth F. Boehm | M | - | 5 ans | |
| Janet Vergis | F | 59 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 5 ans |
| Richard Kollender | M | 54 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Helen Jenkins | F | 60 | - | |
| Maria Hilado | F | 59 | 4 ans | |
| Peter Kaighn Miller | M | 62 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 14 ans |
| Lewis J. Stuart | M | 64 | 2 ans | |
| Lisa M. DeFrancesco | F | 45 | - | |
| Dennis D. Kim | M | 54 | 2 ans | |
| Matthew Walsh | M | 57 | 2 ans | |
| George Esgro | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 13 ans |
| Charles McWherter | M | 69 | 17 ans | |
| Matthew Nguyen | M | 54 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 1 ans |
| Leonard Dove | M | 51 | 2 ans | |
| Bryan Smith | M | 45 | 7 ans | |
| Thomas Nee | M | - | 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 69 | 69,00% |
| Irlande | 21 | 21,00% |
| Canada | 12 | 12,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Eric Lefebvre
- Réseau Personnel
